Razmara Ali, Ovbiagele Bruce, Markovic Daniela, Towfighi Amytis
Department of Neurology, University of California, Irvine, Orange, California.
Department of Neurology, Medical University of South Carolina, Charleston, South Carolina.
J Stroke Cerebrovasc Dis. 2016 Apr;25(4):857-65. doi: 10.1016/j.jstrokecerebrovasdis.2015.12.027. Epub 2016 Jan 14.
Expert consensus guidelines recommend antihypertensive treatment to lower secondary stroke risk, but patterns and predictors of blood pressure (BP) treatment and control among stroke survivors in the United States remain unknown. Understanding predictors of poor control can facilitate development of targeted strategies.
We reviewed the prevalence and control of hypertension among adults 40 years or older with self-reported stroke who participated in the National Health and Nutrition Examination Surveys 1999-2004 with mortality follow-up through 2006. Predictors of poorly controlled BP (>140/90 mm Hg) and nontreatment were determined via logistic regression. Independent association between antihypertensive use and mortality was determined using Cox models.
Among 9145 participants, 490 reported previous stroke; 72% had known hypertension, 8% had undiagnosed hypertension, and 47% had poorly controlled BP. In multivariable analyses, age (odds ratio [OR] per year 1.06, 95% confidence interval [CI] 1.03-1.09), female sex (OR 1.70, 95% CI 1.12-2.57), non-Mexican Hispanic ethnicity (OR 4.54, 95% CI 1.76-11.70), black race (OR 3.15, 95% CI 1.59-6.25), hypercholesterolemia (OR 2.46, 95% CI 1.44-4.21), and diabetes (OR 1.96, 95% CI 1.16-3.33) were associated with poorly controlled BP. Obesity was associated with lower odds of poorly controlled BP (OR .51, 95% CI .26-.99). Non-Mexican Hispanic ethnicity (OR 7.37, 95% CI 2.25-24.10) and black race (OR 3.13, 95% CI 1.05-9.34) were predictors of nontreatment, whereas diabetes was linked to treatment (OR 3.57, 95% CI 1.21-10.43). There was no association between antihypertensive treatment and mortality after adjustment for demographics and comorbidities.
One in 2 stroke survivors in the United States has poorly controlled BP; the most vulnerable groups include women, non-Mexican Hispanics, blacks, diabetics, and older individuals. Understanding causes of this evidence-practice gap may assist in developing effective targeted interventions.
专家共识指南推荐进行抗高血压治疗以降低继发性中风风险,但美国中风幸存者的血压(BP)治疗模式及控制情况的预测因素仍不明确。了解控制不佳的预测因素有助于制定针对性策略。
我们回顾了1999 - 2004年参加美国国家健康与营养检查调查且自我报告有中风史的40岁及以上成年人的高血压患病率及控制情况,并对其进行至2006年的死亡率随访。通过逻辑回归确定血压控制不佳(>140/90 mmHg)和未接受治疗的预测因素。使用Cox模型确定抗高血压药物使用与死亡率之间的独立关联。
在9145名参与者中,490人报告曾患中风;72%患有已知高血压,8%患有未诊断高血压,47%血压控制不佳。在多变量分析中,年龄(每年的优势比[OR]为1.06,95%置信区间[CI]为1.03 - 1.09)、女性(OR为1.70,95% CI为1.12 - 2.57)、非墨西哥裔西班牙裔(OR为4.54,95% CI为1.76 - 11.70)、黑人种族(OR为3.15,95% CI为1.59 - 6.25)、高胆固醇血症(OR为2.46,95% CI为1.44 - 4.21)和糖尿病(OR为1.96,95% CI为1.16 - 3.33)与血压控制不佳相关。肥胖与血压控制不佳的较低几率相关(OR为0.51,95% CI为0.26 - 0.99)。非墨西哥裔西班牙裔(OR为7.37,95% CI为2.25 - 24.10)和黑人种族(OR为3.作3,95% CI为1.05 - 9.34)是未接受治疗的预测因素,而糖尿病与接受治疗相关(OR为3.57,95% CI为1.21 - 10.43)。在对人口统计学和合并症进行调整后,抗高血压治疗与死亡率之间无关联。
美国每2名中风幸存者中就有1人血压控制不佳;最脆弱的群体包括女性、非墨西哥裔西班牙裔、黑人、糖尿病患者和老年人。了解这一证据与实践差距的原因可能有助于制定有效的针对性干预措施。